Smart Ways To Collect Real-World Data For Device Trials

Why would a payer cover an insulin injector that costs patients about $850 more per year than vials of insulin and syringes?. Because, compared to a normal syringe, an insulin injector is significantly safer and easier to use, and therefore leads to fewer complications and better clinical outcomes. This ends up saving patients and physicians money in the long run.

Based on clinical data alone, manufacturers can only speculate on a device’s cost-savings in the real world. The only way to prove the true value of a medical device is to collect real-world data (RWD) on its safety, efficacy and cost outcomes outside of the clinic.